ZyVersa Therapeutics, Inc. has announced the FDA-authorized Emergency Compassionate Use of its investigational drug VAR 200 for a patient with ApoCII amyloidosis, a rare kidney disease characterized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results